CardioComm Solutions, Inc.
EKGGF
$0.01
$0.00-1.35%
OTC PK
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -29.47% | -27.22% | -32.46% | -40.95% | -43.90% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -29.47% | -27.22% | -32.46% | -40.95% | -43.90% |
| Cost of Revenue | 28.89% | -6.14% | -50.15% | -85.61% | -86.92% |
| Gross Profit | -33.01% | -28.58% | -31.28% | -33.35% | -29.79% |
| SG&A Expenses | -8.30% | -22.00% | -27.14% | -24.25% | -2.93% |
| Depreciation & Amortization | 6.70% | 13.04% | 16.85% | 16.57% | -5.37% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -6.38% | -20.33% | -27.14% | -30.98% | -22.16% |
| Operating Income | -39.53% | 2.45% | 6.72% | -31.56% | -235.84% |
| Income Before Tax | -111.52% | -117.78% | -274.90% | -95.54% | -173.27% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -111.52% | -117.78% | -274.90% | -95.54% | -173.27% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -111.52% | -117.78% | -274.90% | -95.54% | -173.27% |
| EBIT | -39.53% | 2.45% | 6.72% | -31.56% | -235.84% |
| EBITDA | -40.04% | 2.59% | 6.85% | -34.01% | -261.15% |
| EPS Basic | -87.50% | -100.00% | -233.33% | -75.00% | -166.67% |
| Normalized Basic EPS | -50.00% | -40.00% | -100.00% | -25.00% | -100.00% |
| EPS Diluted | -87.50% | -100.00% | -233.33% | -75.00% | -166.67% |
| Normalized Diluted EPS | -50.00% | -40.00% | -100.00% | -25.00% | -100.00% |
| Average Basic Shares Outstanding | 20.65% | 27.06% | 20.13% | 13.23% | 6.32% |
| Average Diluted Shares Outstanding | 20.65% | 27.06% | 20.13% | 13.23% | 6.32% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |